Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
100% certainly that human clinical trials will be necessary.
Signed,
Ex-FDAer
Reduced my holding from 2.25M to 1.25M shares today. Made a very tiny profit on the 1M shares I sold. Agree that all biotech startups go through this but the successful ones, when they have what is seen as a highly viable product, have large companies supplying cash in return for a future ROI. We don't see that happening with RDGL and if their product(s) are so revolutionary I would have expected to see it by now. It will be a race against time as to whether they will raise the necessary cash to build their business before running out of funding. I kept more than half my shares in case they make it.
I think the odds of ABHI being relisted are about the same as it not being delisted at the time of your post. Slim to none. We have the same person at the "helm". I've decided not to check this board anymore because I believe the stock will remain dead. A lot of good people on this board (you being one of them) and I wish GLTA.
While Kevin is asking for "investments" for his business, I'm wondering what happened to the proceeds of the PC Drivers lawsuit? Anyone know?
Time will tell. If the stock is still at zero when I do my taxes for this year I write it off. If it should rise up from the ashes one day I'll write it back up from zero when I go sell it. The stock has to be written off for the year it went to zero. The IRS has clear rules for how one does this online.
Time will tell. If the stock is still at zero when I do my taxes for this year I write it off. If it should rise up from the ashes one day I'll write it back up from zero when I go sell it. The stock has to be written off for the year it went to zero. The IRS has clear rules for how one does this online.
Thanks
> I have no doubt you will get us back on track.
I know this is text and can be misinterpreted but I mean with total respect, what makes you think that given what we've experienced for the past year?
Listen to the YouTube videos made by Kevin last year. I made my investment decisions based on what the CEO of the company told current and prospective shareholders. And we were told another company sold millions of dollars of the same software. I consider that about as due diligence as one can get. I feel misinformed. Was it known in September that financials would not be forthcoming? Yet we were told they would be. What happened Kevin? You never responded to that question. It seems that some people on this board have Stockholm Syndrome.
Thanks, but I'm hoping Kevin will reply. I've heard a lot of what will be happening over the last year. The only thing that has happened is we're unlisted and valueless. I want to know why trust him now. At the end of the day regardless of what is promised or not at this point, it will happen or it won't. We'll be relisted after September/October or the financials will be completed by Thanksgiving. Words. I'm not hopeful. I don't think it hopeless, either. I'm realistic and given past performance only results will matter. I'm $15K in the hole because I believed the story. The trust account has been depleted and needs to be regenerated.
It was stated that financials would be current in Fall 2017. Was it known when we were hearing that financials would be current soon that the company was on death's door? That is why from this point on I will sit back and wait to see what happens. Lots of words the past year and of half leading to worthless shares. All those deals that were in the works, the millions and millions of potential customers just over the horizon. Stephen Covey's description of the emotional [trust] bank account is highly relevant. When I see results I'll be a believer again.
Do you know how long clinical trials in humans will take? I'm sure no one can answer that question at this time. It has not been approved as a device for humans.
That would be great should that occur.
Not until safety and efficacy is shown in humans. IsoPet is still being tested in animals. The companion animal drug market is tiny compared to human drugs. We should be higher than we are but we will need to wait for a valuation of several hundred million dollars. Hopefully, not too long of a wait but I'm not thinking months. Human clinical trials and then drug approval is a lengthy process.
Exactly
The answer is no but what would possibly prompt you to ask that question?
How do you know that? A market maker only shows their lowest offer. Any higher offers by that market maker will not be shown. There could be many millions of shares between here and .005. And there are also all the potential sellers that do not have an order in but may jump in at any time and sell shares.
More likely I'll be playing center for the Lakers. Nine years he's had this software. Finally had a publicly traded company through which to make his product a winner. Now is asking for more money to get his software to be a viable product. PC Drivers was able to create, at least from what we've been told, a money maker. What has changed that will lead to a different outcome? As far as I can tell absolutely nothing. Kevin's feet need to be held to the fire. He is accountable and what we get are YouTube videos to appease, raise hope and money. It's sad. I feel sorry for him. I wonder what goes through his mind as he goes to sleep at night. If he had any sort of integrity he would come clean with us as to what happened and his responsibility for what happened. Yet he goes on as if the last year and a half never occurred.
People get scared. I find most investors don't have patience. To hold a stock for more than 6 months or a year is too long for them. There are stocks I've held for years. For example, HEMA went from .18 to $13 and I still haven't sold a single share. When it was at .20 and went down to .14 I bought more.
This is the message I just left on YouTube under Kevin's update:
When you say after Labor Day do you mean in the year 2025 or before then? Does greater shareholder value mean any share price greater than zero, as in .0001? And finally, given that EVERYTHING you have said for the past year has not come to fruition as far as shareholders are concerned, I find it difficult to believe ANYTHING you say. What happened to Kaseya? Not a word about them anymore. What about the financials that you said would be complete by October 2017? I don't know if it was because of incompetency, negligence or dishonesty but I'm $15K in the hole because I was stupid enough to believe what you said in your videos during 2017. I assume the "investment opportunity" is because it is impossible, given past performance, to get a loan from a bank. It's a perfect example of the old saying, "Fool me once shame on you, fool me twice shame on me." No way you'd get any more money from me. You blew the $15K I invested in YOUR company. With all the empty promises that were made I'm shocked that there has yet to be a class action lawsuit filed. I'd love to be proven wrong. I hope you do so.
There may be shares for sale behind that .0042 from the same market maker. Only high bids/offers from a MM will show.
Strange. The moderator misunderstood my message to you and it got deleted. I spent a lot time in the son when I was a kid. Bad sunburns, blistering. After I was 15 I rarely spent time in the sun. However, I'm still at risk given the sun damage I received when I was much younger. That was the point of my message. Staying out of the sun now is the best thing we can do for ourselves but it doesn't eliminate all risk. Hopefully, and more than likely, you will never have a problem. But if any of us do it's good to know that a non-damaging cure is in the works.
Or there's an announcement of import and the stock goes up to a penny. Which is more likely? Perhaps .0027 (52 week low) but just like a casino once in a while one pulls the handle and gets to cash out. This is a company with a real product that has the potential to make an enormous positive impact. That's what I'm BETTING on. Whether it goes to .002 first (yes, I would have wished I bought all my shares there) or not doesn't matter if one is in for the long game. And the company survives. That is the risk. Lose several thousand $ or make a heck of a lot more.
That's what I said in an earlier post and am in total agreement with what you are saying. While not a reviewer, I was in a senior management position at FDA for 10 years. I am much more aware of the review process for drugs than for devices like Radiogel. As a health care provider I wouldn't use anything on a patient unless I knew it was safe and effective to do so. Yes, the efficacy of Yttrium-90 is known but at what dose, for how long and for what cancers is it (most) effective and without causing more harm than good? That is what clinical trials in humans will determine.
My question is why Vivos is not getting larger companies to invest in the development of what looks like potentially breakthrough products? Perhaps this has been discussed before and if so I apologize for bringing it up again.
It may get clearance for humans for skin cancer but I would be shocked if Vivos gets clearance/approval for other tumors in humans without clinical trials. Meanwhile, I don't see large rx companies banging down Vivos' door to get a piece of the action. Perhaps you have thoughts as to why that is.
Given the posts I've been reading it seems that many people don't know or don't understand.
Thanks. I know the study. It was done in mice using a human xenograft tumor model. Human testing, i.e., with people, will need to be done and it will be need to be done by Vivos. Their particular device will need to be tested, regardless of whether or not the efficacy and safety of yttrium-90 is demonstrated in humans by another rx company. You had said "human trials are certainly happening." That is the information I'm looking for. I can't confirm that anywhere I've looked on the web including the Vivos website.
Going back to my earlier post, they need to be able to sell enough of the canine/feline product to generate the income they will need to do the human testing. And/or as you pointed out, have a royalty agreement with or investment by a much larger pharmaceutical company.
From the article you sent--
"The animal testing has a dual purpose. It is also a key pre-clinical test to support human skin cancer therapy.”
That was the point I was making before. As far as I know, clinical testing in humans has yet to begin.
I can't find anything about human trials on their website. There is a menu item that says "Articles and Publications" but it is not an active link. Also a menu item that says brachytherapy but it, too, does not link to a web page. Do have a link that discusses testing Radiogel in humans?
Why do you think milestone payments, etc., have yet to happen with this company?
Needs to be the human side, IMHO, for large rx companies to make those agreements. That's where the money is. Most if not all rx companies no longer have separate animal drug development operations. They are now merged into the entire company. The profits from animal drugs pale in comparison to human drugs for obvious reasons. The current test animals will hopefully demonstrate the safety and efficacy of the gel and then on to human trials.
Totally agree. I wonder if they are pursuing those kinds of agreements similar to the agreements that PIRS has in place, if you're familiar with that company. Perhaps more evidence, i.e., a more robust clinical trial, is what's needed.
The game with this stock, as with most tiny biotechs, is whether or not the company will run out of cash prior to being able to market their product(s) and do so in a way that they start generating significant revenues and earnings. Either they will or they won't. All the talk about dilution, shorting and manipulation becomes meaningless if they have a drug/device that the vet/human health care industry wants and they are able to market and sell their products at a profit.
If I sell to the brokerage firm for .01 if it comes back to life I no longer own the shares. Writing a stock down to zero is the way to take the loss and keep the shares. If it comes back you bought it back at zero when you go to sell it. One needs proof of it being valueless and the day it went to zero for IRS purposes to do the write down. Of course check with the IRS/your brokerage firm as opposed to a message on a bulletin board to decide what works best for you.
I would call him but it's not what he says it's what he does. I will write the stock down to zero on my taxes and write it back up if it ever trades again.
Do you or anyone else know the date our shares became valueless? The "sell" date is the last day of the year but if audited the IRS asks for the date the stock lost its value. Thanks in advance.
Of course I know that. I'm talking about today. ABHI could have started selling to other customers last year. What's the holdup now for Kevin to sell his product? Beta testing of an upgraded dashboard? Give me a break. This whole thing continues to stink.
My guess is that no bank will loan him money, hence this "investment opportunity". It would be a poor business decision on their part given the way in which he managed ABHI and his inability to bring the financials of his company up to date resulting in a current company value of zero. History indicates that loaning money to Kevin would be an extremely high-risk venture.
Hasn't the software been around in one form or another for the past 9 years? They are still beta testing? They don't have software that works? The dashboard needs to be upgraded before they can sell the product? For over a year they touted how it will transform the computer industry and the company they successfully sued (PC Drivers) was making all sorts of money by selling Voosh software. I don't understand this.